BAC
Bank of America Corporation
BAC has the edge over OCSL overall, supported by stronger valuation and stronger fundamentals.
OCSL
Oaktree Specialty Lending Corporation
OCSL trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
OCSL Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| N/A | |
| N/A |
OCSL's profitability is currently stable, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like OCSL.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over OCSL in the historical PE scenario, which offers more potential upside but is not a forecast.
OCSL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.8x | $2.79 | -77% |
| Forward | 8.9x | $12.16 | — |
| Fair | 19x | $8.88 | -27% |
| Current | 25x | $12.16 | — |
| Expensive | 34x | $16.42 | +35% |
Historical ranges are pointers, not guarantees.
OCSL's PE is in its expensive range at 25x. On analysts' estimates for next year's earnings, today's price would be 8.9x, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over OCSL on the outlook, with more favorable earnings and revenue expectations.
OCSL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect OCSL's earnings and profitability to decline, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over OCSL on earnings, with more consistent year-over-year improvement.
OCSL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.36 | +184% |
| Q2 2026 | $0.48 | -14% |
| Q1 2026 | $0.57 | +338% |
| Q4 2025 | $0.36 | -46% |
| Q3 2025 | $0.39 | -46% |
| Q2 2025 | $0.56 | -38% |
| Q1 2025 | $0.13 | -91% |
| Q4 2024 | $0.67 | -57% |
| Q3 2024 | $0.72 | -56% |
OCSL's earnings per share have fallen from their peak: $0.48 over the past year, against $7.24 in early 2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus down 32% for OCSL.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
OCSL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2022 | $32.8M | -32% |
| Q1 2022 | $25.6M | -74% |
| Q4 2021 | $51.5M | -30% |
| Q3 2021 | $48M | -39% |
| Q2 2021 | $59.2M | -54% |
| Q4 2020 | $73.7M | +168% |
| Q3 2020 | $78.3M | +227% |
OCSL's revenue has slid since its 2020 peak: $33M last quarter, down 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2022 | 46% | -31 points |
| Q1 2022 | 56% | -35 points |
| Q4 2021 | 78% | -11 points |
| Q3 2021 | 77% | -13 points |
| Q2 2021 | 82% | -11 points |
| Q1 2021 | 91% | N/A |
| Q4 2020 | 89% | +38 points |
| Q3 2020 | 90% | +30 points |
OCSL's operating margin was 46% last quarter, down 36 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
OCSL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $57.6M | +173% |
| Q1 2026 | $130.7M | +111% |
| Q4 2025 | -$83.5M | -158% |
| Q3 2025 | $1.3M | -99% |
| Q2 2025 | $21.1M | +$81M |
| Q1 2025 | $62M | +$79.6M |
| Q4 2024 | $144M | +12696% |
| Q3 2024 | $95.5M | -61% |
OCSL has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over OCSL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
OCSL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | +14% | +11M shares |
| 5 years | +47% | +28M shares |
| Available history | +87% | +41.1M shares |
OCSL has 88M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $1.1M |
| Q1 2026 | $1.1M |
| Q4 2025 | $1.1M |
| Q3 2025 | $1.2M |
| Q2 2025 | $3.8M |
| Q1 2025 | $4.3M |
| Q4 2024 | $1.5M |
| Q3 2024 | $1.6M |
OCSL spent $5M buying back its own shares over the past year, down 59% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
OCSL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | 38.9x | High |
| Q2 2022 | 24.2x | High |
| Q1 2022 | 9.4x | High |
| Q4 2021 | 5.8x | High |
| Q3 2021 | 5.2x | High |
| Q2 2021 | 3.7x | Elevated |
| Q1 2021 | 3.1x | Elevated |
| Q4 2020 | 2.7x | Moderate |
OCSL's net debt is more than 20 years of its operating earnings (EBITDA), up from 5.2 years a year ago. Net leverage isn't a meaningful measure for financial services companies like OCSL.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
OCSL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.4 | Neutral |
| Stochastic | 50.3 | Neutral |
OCSL's weekly RSI is 49 (neutral) and its Stochastic is 50 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over OCSL on valuation relative to its sector.
OCSL PE vs Financial Services Sector
| Metric | OCSL | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 13x | 95% above |
| PE % | 75 | 63 | 12 pts above |
OCSL is trading at 25x earnings, a 95% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
OCSL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.9 | 1.9% above |
| 20 week MA | $12.3 | 0.8% below |
| 50 week MA | $12.2 | 0.4% below |
| 100 week MA | $13.3 | 8.5% below |
| 200 week MA | $16.1 | 24% below |
OCSL has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 24% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
OCSL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.4 | $16.7 | +1.6% |
| 2021 | $16.7 | $22.5 | +35% |
| 2022 | $22.5 | $20.6 | -8.7% |
| 2023 | $20.6 | $20.4 | -0.6% |
| 2024 | $20.4 | $15.3 | -25% |
| 2025 | $15.3 | $12.8 | -16% |
| 2026 YTD | $12.8 | $12.2 | -4.9% |
OCSL has the edge over BAC on returns for 2026, with the stronger performance.